Bone Biologics Corporation Share Price Other OTC
Equities
BBLG
US0980702049
Medical Equipment, Supplies & Distribution
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.69M 135M |
---|---|---|---|---|---|
Net income 2024 * | -8M -639M | Net income 2025 * | -8M -639M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.06
x | P/E ratio 2025 * |
-0.06
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.85% |
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Frelick
CEO | Chief Executive Officer | 59 | 16/08/15 |
Deina Walsh
DFI | Director of Finance/CFO | 60 | 31/10/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bruce Stroever
BRD | Director/Board Member | 75 | 31/12/11 |
Don Hankey
CHM | Chairman | 81 | 15/07/18 |
Robert Gagnon
BRD | Director/Board Member | 49 | 01-07 |
1st Jan change | Capi. | |
---|---|---|
+10.39% | 126B | |
-6.86% | 10.96B | |
+2.52% | 8.97B | |
+38.96% | 5.56B | |
-17.50% | 4.99B | |
+8.36% | 3.44B | |
-8.84% | 2.8B | |
-7.52% | 2.18B | |
-3.00% | 2.16B |